Goserelin Included in Latest NCCN Breast Cancer Guidelines :

The NCCN Breast Cancer Panel has included goserelin at 2 dosing schedules as a method for ovarian function suppression in their updated guidelines.

Related Keywords

Texas , United States , Japan , Japanese , , Mays Cancer Center , Tersera Therapeutics , National Comprehensive Cancer Network , Breast Cancer Panel , Division Of Hematology , Practice Guidelines , Medical Oncology , Texas Health Sciences Center San Antonio , Anderson Cancer Center , Breast Cancer , Sera Therapeutics , Nccn Breast Cancer Guidelines , Goserelin , Dosing Schedules , Ovarian Function Suppression , Updates Guidelines , Zoladex , Version 1 2024 ,